Elias Granizo

A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

X.A. Alvarez, R Cacabelos, M. Laredo et al. · European Journal of Neurology · 2006 · 98 citations

Medicine, Neurology, Pharmacology +15

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double‐blind, controlled trial investigating three dosages of Cerebrolysin

X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro et al. · European Journal of Neurology · 2010 · 70 citations

Medicine, Neurology, Pharmacology +13

Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil

X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro et al. · Current Alzheimer Research · 2011 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +17

Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases

X.A. Alvarez, Irene Álvarez, Olalla Iglesias et al. · The International Journal of Neuropsychopharmacology · 2016 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17